IL60839A - Divisible tablet having controlled and delayed release of a pharmaceutically active substance - Google Patents

Divisible tablet having controlled and delayed release of a pharmaceutically active substance

Info

Publication number
IL60839A
IL60839A IL60839A IL6083980A IL60839A IL 60839 A IL60839 A IL 60839A IL 60839 A IL60839 A IL 60839A IL 6083980 A IL6083980 A IL 6083980A IL 60839 A IL60839 A IL 60839A
Authority
IL
Israel
Prior art keywords
controlled
active substance
pharmaceutically active
delayed release
divisible tablet
Prior art date
Application number
IL60839A
Other languages
English (en)
Other versions
IL60839A0 (en
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH7514/79A external-priority patent/CH648754A5/de
Priority claimed from CH395980A external-priority patent/CH646330A5/de
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of IL60839A0 publication Critical patent/IL60839A0/xx
Publication of IL60839A publication Critical patent/IL60839A/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • A61J3/10Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of compressed tablets
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
IL60839A 1979-08-16 1980-08-14 Divisible tablet having controlled and delayed release of a pharmaceutically active substance IL60839A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH7514/79A CH648754A5 (en) 1979-08-16 1979-08-16 Pharmaceutical slow release tablet
CH395980A CH646330A5 (en) 1980-05-21 1980-05-21 Divisible slow-release pharmaceutical tablets

Publications (2)

Publication Number Publication Date
IL60839A0 IL60839A0 (en) 1980-10-26
IL60839A true IL60839A (en) 1983-11-30

Family

ID=25694276

Family Applications (1)

Application Number Title Priority Date Filing Date
IL60839A IL60839A (en) 1979-08-16 1980-08-14 Divisible tablet having controlled and delayed release of a pharmaceutically active substance

Country Status (20)

Country Link
US (1) US4353887A (cs)
AU (1) AU531058B2 (cs)
CA (1) CA1158555A (cs)
DE (1) DE3030622C2 (cs)
DK (1) DK153772C (cs)
ES (1) ES494274A0 (cs)
FI (1) FI76691C (cs)
FR (1) FR2462908A1 (cs)
GB (1) GB2057878B (cs)
GR (1) GR69943B (cs)
IE (1) IE50108B1 (cs)
IL (1) IL60839A (cs)
IT (1) IT1145285B (cs)
LU (1) LU82718A1 (cs)
MY (1) MY8700198A (cs)
NL (1) NL8004616A (cs)
NO (1) NO156274C (cs)
NZ (1) NZ194681A (cs)
PT (1) PT71706B (cs)
SE (1) SE445802B (cs)

Families Citing this family (111)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN158328B (cs) * 1981-03-09 1986-10-18 Ici Plc
JPS5839618A (ja) * 1981-09-04 1983-03-08 Chugai Pharmaceut Co Ltd 持続性積層錠剤
JPS58152813A (ja) * 1982-03-08 1983-09-10 Sumitomo Chem Co Ltd 鮮明な刻印を有する錠剤およびその製法
DK152744C (da) * 1982-08-13 1988-10-31 Benzon As Alfred Fremgangsmaade til fremstilling af et farmaceutisk peroralt polydepotpraeparat
DK151608C (da) * 1982-08-13 1988-06-20 Benzon As Alfred Fremgangsmaade til fremstilling af et farmaceutisk peroralt polydepotpraeparat med kontrolleret afgivelse
US4503031A (en) * 1982-12-17 1985-03-05 Glassman Jacob A Super-fast-starting-sustained release tablet
DE3314003A1 (de) * 1983-04-18 1984-10-18 Boehringer Ingelheim KG, 6507 Ingelheim Teilbare tablette mit verzoegerter wirkstofffreigabe und verfahren zu deren herstellung
US4591500A (en) * 1983-04-25 1986-05-27 Microencapsulation S.A. Tablet having the shape of a capsule, process and device for its preparation
JPS604120A (ja) * 1983-06-22 1985-01-10 Shionogi & Co Ltd 作用持続型ピナシジル製剤
DE3505433A1 (de) * 1985-02-16 1986-08-21 Basf Ag, 6700 Ludwigshafen Direkttablettierhilfsmittel
US4631305A (en) * 1985-03-22 1986-12-23 The Upjohn Company Polymeric material as a disintegrant in a compressed tablet
ES2041336T3 (es) * 1987-11-20 1993-11-16 Greither, Peter Capsula y procedimiento para su fabricacion.
US5051261A (en) * 1987-11-24 1991-09-24 Fmc Corporation Method for preparing a solid sustained release form of a functionally active composition
KR940000280Y1 (ko) * 1987-12-17 1994-01-19 디 엎죤 캄파니 3중 스코어(score)를 가진 약 정제
USD315223S (en) 1989-05-03 1991-03-05 Warner-Lambert Company Tablet
EP0418565B1 (en) * 1989-09-21 1994-11-30 American Cyanamid Company Pulsatile once-a-day delivery system for minocycline
EP0418596A3 (en) * 1989-09-21 1991-10-23 American Cyanamid Company Controlled release pharmaceutical compositions from spherical granules in tabletted oral dosage unit form
US5009896A (en) * 1989-10-04 1991-04-23 Akzo N.V. Multi-fractionable tablet structure
US5213738A (en) * 1990-05-15 1993-05-25 L. Perrigo Company Method for making a capsule-shaped tablet
US5061494A (en) * 1990-06-14 1991-10-29 The Upjohn Comany Tri-scored drug tablet
DE4100920A1 (de) * 1991-01-15 1992-07-16 Degussa Wirkstoffzubereitung zur oralen verabreichung an wiederkaeuer
GB9101502D0 (en) * 1991-01-23 1991-03-06 Controlled Therapeutics Sct Controlled release compositions
US5262173A (en) * 1992-03-02 1993-11-16 American Cyanamid Company Pulsatile once-a-day delivery systems for minocycline
USD361837S (en) 1993-06-28 1995-08-29 Solvay-Duphar B.V. Breakable tablet
US5398851A (en) * 1993-08-06 1995-03-21 River Medical, Inc. Liquid delivery device
US5398850A (en) * 1993-08-06 1995-03-21 River Medical, Inc. Gas delivery apparatus for infusion
US5571261A (en) * 1993-08-06 1996-11-05 River Medical, Inc Liquid delivery device
FR2709420B1 (fr) * 1993-09-01 1995-11-17 Sogeval Comprimé vétérinaire plus spécialement destiné aux chats.
US6080428A (en) 1993-09-20 2000-06-27 Bova; David J. Nicotinic acid compositions for treating hyperlipidemia and related methods therefor
US6746691B2 (en) 1993-09-20 2004-06-08 Kos Pharmaceuticals, Inc. Intermediate release nicotinic acid compositions for treating hyperlipidemia having unique biopharmaceutical characteristics
US6818229B1 (en) 1993-09-20 2004-11-16 Kos Pharmaceuticals, Inc. Intermediate release nicotinic acid compositions for treating hyperlipidemia
US6129930A (en) * 1993-09-20 2000-10-10 Bova; David J. Methods and sustained release nicotinic acid compositions for treating hyperlipidemia at night
US6676967B1 (en) 1993-09-20 2004-01-13 Kos Pharmaceuticals, Inc. Methods for reducing flushing in individuals being treated with nicotinic acid for hyperlipidemia
US5700245A (en) * 1995-07-13 1997-12-23 Winfield Medical Apparatus for the generation of gas pressure for controlled fluid delivery
US5756124A (en) * 1995-08-07 1998-05-26 Invamed, Inc. Multi-scored pharmaceutical tablets
GB9613470D0 (en) 1996-06-27 1996-08-28 Ciba Geigy Ag Small solid oral dosage form
GB9624563D0 (en) * 1996-11-27 1997-01-15 Smithkline Beecham Plc Product
ES2302364T3 (es) * 1998-04-03 2008-07-01 Kyowa Hakko Kogyo Co., Ltd. Tableta divisible y paquete perforado por presion.
US6602521B1 (en) * 1998-09-29 2003-08-05 Impax Pharmaceuticals, Inc. Multiplex drug delivery system suitable for oral administration
DE19856147A1 (de) 1998-12-04 2000-06-08 Knoll Ag Teilbare feste Dosierungsformen und Verfahren zu ihrer Herstellung
AU5551800A (en) * 1999-06-23 2001-01-31 Eu Pharma Ltd. Divisible tablets
GB9914620D0 (en) * 1999-06-23 1999-08-25 Eu Pharma Ltd Divisible tablets
USD440650S1 (en) 2000-01-27 2001-04-17 Watson Pharmaceuticals, Inc. Tablet
SE0100200D0 (sv) * 2001-01-24 2001-01-24 Astrazeneca Ab New film coating
US7776314B2 (en) 2002-06-17 2010-08-17 Grunenthal Gmbh Abuse-proofed dosage system
TW200502000A (en) * 2003-03-28 2005-01-16 Kyowa Hakko Kogyo Kk Dividing tablet
DE10361596A1 (de) 2003-12-24 2005-09-29 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
US20070048228A1 (en) 2003-08-06 2007-03-01 Elisabeth Arkenau-Maric Abuse-proofed dosage form
DE102004032051A1 (de) 2004-07-01 2006-01-19 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten, festen Darreichungsform
US8075872B2 (en) 2003-08-06 2011-12-13 Gruenenthal Gmbh Abuse-proofed dosage form
DE10336400A1 (de) 2003-08-06 2005-03-24 Grünenthal GmbH Gegen Missbrauch gesicherte Darreichungsform
DE102005005446A1 (de) 2005-02-04 2006-08-10 Grünenthal GmbH Bruchfeste Darreichungsformen mit retardierter Freisetzung
CA2537060A1 (en) 2003-09-03 2005-03-10 Novartis Ag Use of oxcarbazepine for the treatment of diabetic neuropathic pain and the improvement of sleep
FR2859632B1 (fr) * 2003-09-15 2005-11-18 Arrow Generiques Comprime multisecable a observance amelioree.
DE202004002700U1 (de) * 2004-02-20 2004-04-29 Desitin Arzneimittel Gmbh Viertelbare Tablette
US7838031B2 (en) * 2004-05-21 2010-11-23 Lawrence Solomon Method of administering a partial dose using a segmented pharmaceutical tablet
CN1960712B (zh) * 2004-05-21 2011-04-20 阿库-伯雷克技术公司 包含多个片段的刻痕药片
WO2006038916A2 (en) * 2004-05-21 2006-04-13 Accu-Break Technologies, Inc. Scored pharmaceutical tablets comprising a plurality of segments
DE102004032049A1 (de) 2004-07-01 2006-01-19 Grünenthal GmbH Gegen Missbrauch gesicherte, orale Darreichungsform
GB0423964D0 (en) * 2004-10-28 2004-12-01 Jagotec Ag Dosage form
DE102005005449A1 (de) 2005-02-04 2006-08-10 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
EP1712224A1 (en) * 2005-04-12 2006-10-18 Alexander von Mérey Divisible rectangular flat tablet
ES2620293T3 (es) 2005-09-09 2017-06-28 Paladin Labs Inc. Composición de liberación sostenida de fármacos
TWI274889B (en) * 2005-10-06 2007-03-01 Elan Microelectronics Corp Resistive touch screen measurement system
US20070160960A1 (en) * 2005-10-21 2007-07-12 Laser Shot, Inc. System and method for calculating a projectile impact coordinates
US7985419B1 (en) 2006-12-22 2011-07-26 Watson Laboratories, Inc. Divisible tablet and associated methods
DE102007011485A1 (de) 2007-03-07 2008-09-11 Grünenthal GmbH Darreichungsform mit erschwertem Missbrauch
US20080286343A1 (en) * 2007-05-16 2008-11-20 Dzenana Cengic Solid form
US20080286344A1 (en) * 2007-05-16 2008-11-20 Olivia Darmuzey Solid form
WO2008140461A1 (en) * 2007-05-16 2008-11-20 Fmc Corporation Solid form
US20080311162A1 (en) * 2007-05-16 2008-12-18 Olivia Darmuzey Solid form
WO2008140460A1 (en) * 2007-05-16 2008-11-20 Fmc Corporation Solid form
WO2008140459A1 (en) * 2007-05-16 2008-11-20 Fmc Corporation Solid form
WO2009092601A1 (en) 2008-01-25 2009-07-30 Grünenthal GmbH Pharmaceutical dosage form
FR2928836B1 (fr) * 2008-03-21 2011-08-26 Servier Lab Forme galenique secable permettant une liberation modifiee du principe actif
CA2723438C (en) 2008-05-09 2016-10-11 Gruenenthal Gmbh Process for the preparation of an intermediate powder formulation and a final solid dosage form under usage of a spray congealing step
USD589606S1 (en) 2008-06-03 2009-03-31 Solvay Pharmaceuticals B.V. Pharmaceutical tablet
TW201006473A (en) * 2008-08-13 2010-02-16 Orient Pharma Co Ltd Bi-layer medicine tablet containing Zaleplon
US20100104687A1 (en) * 2008-10-24 2010-04-29 Kaplan Allan S Segmented confectionery products
WO2011009602A1 (en) 2009-07-22 2011-01-27 Grünenthal GmbH Hot-melt extruded controlled release dosage form
PE20120572A1 (es) 2009-07-22 2012-06-06 Gruenenthal Chemie Forma de dosificacion de oxidacion estabilizada resistente a la manipulacion
EP2531176B1 (en) 2010-02-03 2016-09-07 Grünenthal GmbH Preparation of a powdery pharmaceutical composition by means of an extruder
PE20131102A1 (es) 2010-09-02 2013-10-12 Gruenenthal Chemie Forma de dosificacion resistente a manipulacion que comprende una sal inorganica
TWI516286B (zh) 2010-09-02 2016-01-11 歌林達股份有限公司 含陰離子聚合物之抗破碎劑型
JO3283B1 (ar) 2011-04-26 2018-09-16 Sanofi Sa تركيب يتضمن أفليبيرسيبت, حمض فولينيك, 5- فلورويوراسيل (5- Fu) وإرينوسيتان (FOLFIRI)
LT2736495T (lt) 2011-07-29 2017-11-10 Grünenthal GmbH Sugadinimui atspari tabletė, pasižyminti greitu vaisto atpalaidavimu
DK2736497T3 (da) 2011-07-29 2017-11-13 Gruenenthal Gmbh Stød-resistent tablet, der tilvejebringer en øjeblikkelig frigivelse af et lægemiddel.
CA2864949A1 (en) 2012-02-28 2013-09-06 Grunenthal Gmbh Tamper-resistant dosage form comprising pharmacologically active compound and anionic polymer
RS57913B1 (sr) 2012-04-18 2019-01-31 Gruenenthal Gmbh Farmaceutske dozne forme otporne na neovlašćenu upotrebu i naglo oslobađanje celokupne doze
US10064945B2 (en) 2012-05-11 2018-09-04 Gruenenthal Gmbh Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc
US20140141078A1 (en) * 2012-09-15 2014-05-22 Jeffery K. Slaboden Dissolvable TableT
US10154966B2 (en) 2013-05-29 2018-12-18 Grünenthal GmbH Tamper-resistant dosage form containing one or more particles
AR096438A1 (es) 2013-05-29 2015-12-30 Gruenenthal Gmbh Forma de dosificación resistente al uso indebido con perfil de liberación bimodal, proceso
MX368846B (es) 2013-07-12 2019-10-18 Gruenenthal Gmbh Forma de dosificación resistente a la alteración que contiene polímero de acetato de etilen-vinilo.
EP3073994A1 (en) 2013-11-26 2016-10-05 Grünenthal GmbH Preparation of a powdery pharmaceutical composition by means of cryo-milling
USD723155S1 (en) 2014-02-11 2015-02-24 Pharmavite Llc Tablet
JP2017518980A (ja) 2014-05-12 2017-07-13 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング タペンタドールを含む、改変防止即時放出カプセル製剤
US9872835B2 (en) 2014-05-26 2018-01-23 Grünenthal GmbH Multiparticles safeguarded against ethanolic dose-dumping
LT3170005T (lt) 2014-07-18 2019-07-10 Sanofi Paciento, įtariamo, kad serga vėžiu, gydymo afliberceptu rezultato prognozavimo būdas
JP2018517676A (ja) 2015-04-24 2018-07-05 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング 即時放出および溶媒抽出に対する耐性を有する改変防止製剤
US10842750B2 (en) 2015-09-10 2020-11-24 Grünenthal GmbH Protecting oral overdose with abuse deterrent immediate release formulations
USD805726S1 (en) * 2016-03-11 2017-12-26 Mars, Incorporated Pet food
USD869117S1 (en) 2018-08-22 2019-12-10 Land O'lakes, Inc. Butter stick
USD909825S1 (en) 2018-08-22 2021-02-09 Land O'lakes, Inc. Die
USD869116S1 (en) 2018-08-22 2019-12-10 Land O'lakes, Inc. Butter stick
USD909148S1 (en) 2018-08-22 2021-02-02 Land O'lakes, Inc. Die
US20200060218A1 (en) 2018-08-22 2020-02-27 Land O'lakes, Inc. Extruded, multi-portioned butter products and system and methods of producing same
USD871016S1 (en) 2019-05-10 2019-12-31 Land O'lakes, Inc. Butter stick
USD918526S1 (en) 2019-11-12 2021-05-11 Land O'lakes, Inc. Butter stick
EP4121013B1 (en) * 2020-03-16 2025-01-15 Grünenthal GmbH Scored tablet comprising tapentadol
US20210378968A1 (en) * 2020-05-28 2021-12-09 Johnson & Johnson Consumer Inc. Multi-cavity customizable dosage forms

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE104533C1 (cs) *
GB189400A (en) * 1922-05-02 1922-11-30 Fred William Walton Improvements in the manufacture of chocolate cakes
GB238264A (en) * 1924-04-09 1925-08-10 Henry Charles Clark Improvements relating to table jellies
US1836604A (en) * 1929-06-01 1931-12-15 Simon M Meyer Sugar unit
US2052376A (en) * 1933-05-18 1936-08-25 Edgar G Zellers Insoluble pill or tablet for internal medicinal uses
USD91644S (en) 1933-12-22 1934-03-06 Alex Blackstone Design for a proprietary medicine bar
US2132690A (en) * 1937-06-03 1938-10-11 Perley A Hilliard Edible material in ribbon form
US2410110A (en) * 1943-01-14 1946-10-29 Brewer & Company Inc Method of making tablets
US2410417A (en) * 1944-03-04 1946-11-05 Lever Brothers Ltd Vitamin and mineral dietary supplement and method of making
US2953497A (en) * 1953-06-03 1960-09-20 Howard A Press Therapeutic tablets
US2996431A (en) * 1953-12-16 1961-08-15 Barry Richard Henry Friable tablet and process for manufacturing same
US2811483A (en) * 1954-12-09 1957-10-29 Pfizer & Co C Pharmaceutical composition and process for preparing the same
US2853420A (en) * 1956-01-25 1958-09-23 Lowey Hans Ethyl cellulose coatings for shaped medicinal preparations
GB1022171A (en) * 1961-06-15 1966-03-09 Wellcome Found Prolonged release oral pharmaceutical tablets and their manufacture
US3166476A (en) * 1961-09-01 1965-01-19 Lowey Hans Powder based tablets
GB993291A (en) * 1961-12-06 1965-05-26 Thomas Lee Cooper Tablets, pills, pellets and the like
US3115441A (en) * 1962-06-06 1963-12-24 Victor M Hermelin Timed release pharmaceutical preparations and method of making the same
BE632692A (cs) * 1963-05-28
US3336200A (en) * 1963-05-28 1967-08-15 Warner Lambert Pharmaceutical Tablet structure
FI44458B (cs) * 1963-06-18 1971-08-02 Ucb Sa
USD202467S (en) 1963-10-07 1965-10-05 Jacques Guilmot Pharmaceutical tablets
USD201497S (en) 1964-09-28 1965-06-29 Warner Lambert Co Tablet
FR1603314A (en) * 1965-02-23 1971-04-05 Pharmaceutical tablets - having a core and a matrix material
CH502891A (de) * 1967-11-21 1971-02-15 Ciba Geigy Ag Technische, gekerbte Tablette
GB1368574A (en) * 1971-02-12 1974-10-02 Ives Lab Inc Divisible tablet
GB1387643A (en) * 1971-03-16 1975-03-19 Ives Lab Inc Divisible tablet
US3883647A (en) * 1972-12-06 1975-05-13 Ives Lab Tablet formulation
US4258027A (en) * 1979-03-26 1981-03-24 Mead Johnson & Company Multi-fractionable tablet structure
US4215104A (en) * 1979-03-26 1980-07-29 Mead Johnson & Company Multi-fractionable tablet structure

Also Published As

Publication number Publication date
GB2057878A (en) 1981-04-08
DK153772C (da) 1989-01-23
LU82718A1 (de) 1981-03-24
PT71706B (en) 1981-06-17
IE50108B1 (en) 1986-02-19
GB2057878B (en) 1983-07-20
DE3030622A1 (de) 1981-03-26
NO156274C (no) 1987-08-26
FI802542A7 (fi) 1981-02-17
IL60839A0 (en) 1980-10-26
NL8004616A (nl) 1981-02-18
IE801727L (en) 1981-02-16
CA1158555A (en) 1983-12-13
FI76691C (fi) 1988-12-12
PT71706A (en) 1980-09-01
FR2462908B1 (cs) 1983-07-08
ES8106231A1 (es) 1981-08-01
GR69943B (cs) 1982-07-21
IT8049501A0 (it) 1980-08-14
ES494274A0 (es) 1981-08-01
IT1145285B (it) 1986-11-05
NZ194681A (en) 1983-06-17
NO802447L (no) 1981-02-17
DK354580A (da) 1981-02-17
FI76691B (fi) 1988-08-31
US4353887A (en) 1982-10-12
NO156274B (no) 1987-05-18
MY8700198A (en) 1987-12-31
SE8005759L (sv) 1981-02-17
FR2462908A1 (fr) 1981-02-20
SE445802B (sv) 1986-07-21
DK153772B (da) 1988-09-05
DE3030622C2 (de) 1996-05-30
AU531058B2 (en) 1983-08-11
AU6148180A (en) 1981-02-19

Similar Documents

Publication Publication Date Title
IL60839A (en) Divisible tablet having controlled and delayed release of a pharmaceutically active substance
ZA805015B (en) Divisible tablet having controlled and delayed release of the active substance
EP0018605A3 (en) Enterosoluble capsule and methods for its preparation
JPS5646822A (en) Medicine controlling active component release
HU179474B (en) Process for preparing solid oral pharmaceutical compositons with increased length of activity and with a regulated release of the active material
GB2046209B (en) Encapsulation of chemically active biologically active materials and viable tissue
PH17548A (en) Pharmacologically active substituted-3-amino-sydnone-imines and process for their preparation
DE2856901D2 (de) Form of implant medicament and preparation process
JPS5618982A (en) Pyrimidine derivatives and medicinal drug containing them
IL81232A0 (en) Pharmaceutical composition with sustained release of the active component and a process for the preparation thereof
EG14486A (en) Insecticidally active acyl-ureas and their manufacture and use
JPS5697257A (en) Pharmaceutically active peptides
PT71066A (en) Process for the preparation of a pharmaceutical composition having analgesic and myotonolytical activity
ZA78550B (en) Preparation of insecticides and acaricides
IL59764A0 (en) Drug on the basis of dihydroergo-toxine and procedure for its manufacture
JPS5697258A (en) Pharmaceutically active peptides
IL61764A0 (en) Solutions of bormoxynil and ioxynil esters
JPS56131509A (en) Agricultural drug and manufacture
JPS55100314A (en) Continuously releasing drug composition
CS183843B2 (en) Insecticide and acaricide agent and mode of production of active substances
GB2016012B (en) Pharmaceutically active decahydro-isoquinoline derivatives
PT67341A (en) Process for the preparation of a new insecticidal and acaricidal composition containing a combination of active substances
GB2030140B (en) Pharmaceutically active indane derivatives
GB2001634B (en) Pharmaceutically active compound methods for the preparation and use thereof
JPS55147247A (en) Therapeutically active salicylamide esters* their manufacture and related pharmaceutical composition

Legal Events

Date Code Title Description
HC Change of name of proprietor(s)
KB Patent renewed